The study on risk factors for prostate cancer according to production of equol, a metabolite of isoflavone.
Project/Area Number |
19390176
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Public health/Health science
|
Research Institution | Sapporo Medical University |
Principal Investigator |
MORI Mitsuru Sapporo Medical University, 医学部, 教授 (50175634)
|
Co-Investigator(Kenkyū-buntansha) |
TSUKAMOTO Taiji 札幌医科大学, 医学部, 教授 (50112454)
MASUMORI Naoya 札幌医科大学, 医学部, 准教授 (20295356)
|
Project Period (FY) |
2007 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥13,650,000 (Direct Cost: ¥10,500,000、Indirect Cost: ¥3,150,000)
Fiscal Year 2009: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2008: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2007: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
|
Keywords | 前立腺がん / 症例対照研究 / イソフラボン / エコール / 前立腺がんの家族歴 / 乳がんの家族歴 / 体重増加 / 交互作用 / リスク要因 / エクオール / ダイゼイン / ゲニステイン / グリシテイン |
Research Abstract |
For equol producers with prostate cancer (PCa), family history of PCa, family history of breast cancer and weight gain≧10kg from 20 years old were significantly associated with elevated risk of PCa. Contrastly, for equol non-producer with PCa, family history of PCa was significantly associated with increased risk of PCa, but family history of breast cancer as well as weight gain≧10kg from 20 years old were not associated with risk of PCa. Accordingly, it has been suggested that a risk factor for PCa may be different between equol producer and equol non-producers.
|
Report
(4 results)
Research Products
(14 results)